Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2014

Guancial EA, Werner L, Bellmunt J, Bamias A, Choueiri TK, Ross R, et al. FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder. Cancer Med. 2014;3(4):835-44.

Wu R, Zippin JH, Magro C. Double-positive CD4(+)CD8(+) Sézary syndrome: an unusual phenotype with an aggressive clinical course. Cutis. 2014;93(2):E18-25.

Chang KH, Sengupta A, Nayak RC, Duran A, Lee SJ, Pratt RG, et al. p62 is required for stem cell/progenitor retention through inhibition of IKK/NF-κB/Ccl4 signaling at the bone marrow macrophage-osteoblast niche. Cell Rep. 2014;9(6):2084-97.

Fattah FJ, Hara K, Fattah KR, Yang C, Wu N, Warrington R, et al. The transcription factor TFII-I promotes DNA translesion synthesis and genomic stability. PLoS Genet. 2014;10(6):e1004419.

Prandi D, Baca SC, Romanel A, Barbieri CE, Mosquera J-, Fontugne J, et al. Unraveling the clonal hierarchy of somatic genomic aberrations. Genome Biol. 2014;15(8):439.

Yemelyanova A, Gown AM, Wu L-, Holmes BJ, Ronnett BM, Vang R. PAX8 expression in uterine adenocarcinomas and mesonephric proliferations. Int J Gynecol Pathol. 2014;33(5):492-9.

Lee W, Teckie S, Wiesner T, Ran L, Granada CN, Lin M, et al. PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors. Nat Genet. 2014;46(11):1227-32.

Ogunrinade O, Ahn CS, Gergis U, Yassin AH, Magro C. Cutaneous lymphocyte antigen expression loss and PD1 positivity in early cutaneous lesions of rapidly progressive mycosis fungoides. Clin Case Rep. 2014;2(5):209-18.

Epstein JI, Amin MB, Beltran H, Lotan TL, Mosquera J-, Reuter VE, et al. Proposed morphologic classification of prostate cancer with neuroendocrine differentiation. Am J Surg Pathol. 2014;38(6):756-67.

Osborne JR, Green DA, Spratt DE, Lyashchenko S, Fareedy SB, Robinson BD, et al. A prospective pilot study of (89)Zr-J591/prostate specific membrane antigen positron emission tomography in men with localized prostate cancer undergoing radical prostatectomy. J Urol. 2014;191(5):1439-45.